Clinical trial
Insulin Resistance in Women With Prolactinoma
NCT00481299 · Universidade Federal do Rio de Janeiro, Other · Completed
Key facts
| NCT number | NCT00481299 |
|---|---|
| Title | Insulin Resistance in Women With Prolactinoma |
| Official title | Insulin Resistance and Lipid Profile in Non-Obese Women With Prolactinoma Treated With Dopamine Agonists |
| Lead sponsor | Universidade Federal do Rio de Janeiro, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Prolactinoma, Insulin Resistance, Hyperlipidemia |
| Enrollment | 2,004 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Jun 1, 2007 |
| Last update posted | Jun 1, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: